Capecitabine and oxaliplatin for advanced esophagogastric cancer. - sprookjes - yvandenbroek - TriplyDB

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

http://www.wikidata.org/entity/Q33313072

about

Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma Treatment of gastric cancer Critical appraisal of trastuzumab in treatment of advanced stomach cancer The European Medicines Agency review of Tegafur/Gimeracil/Oteracil (Teysuno™) for the treatment of advanced gastric cancer when given in combination with cisplatin: summary of the Scientific Assessment of the Committee for medicinal products for hum Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-esophageal junction adenocarcinoma Current and emerging therapies in unresectable and recurrent gastric cancer Palliation of Dysphagia in Carcinoma Esophagus Taxanes in the Treatment of Advanced Gastric Cancer Advanced gastric cancer: Current treatment landscape and future perspectives Novel targets in the treatment of advanced gastric cancer: a perspective review Clinical modalities for management of gastric cancer hepatic metastasis Systemic therapy of non-colorectal gastrointestinal malignancies in the elderly Chemotherapy in Elderly Patients with Gastric Cancer Emerging role of S-1 in gastric cancer Clinical significance of MET in gastric cancer Second-line treatment of metastatic gastric cancer: Current options and future directions State of the art management of metastatic gastroesophageal cancer Companion diagnostics for the targeted therapy of gastric cancer Immunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigations Clinical utility of ramucirumab in advanced gastric cancer Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysis Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy Multimodal treatment of gastric cancer in the west: Where are we going?Critical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancers Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy Efficacy of S-1 vs capecitabine for the treatment of gastric cancer: a meta-analysis Helicobacter pylori and interleukin-8 in gastric cancer S-1-based vs non-S-1-based chemotherapy in advanced gastric cancer: a meta-analysis Gastric cancer review Novel CD9-targeted therapies in gastric cancer Hepatoid adenocarcinoma of the stomach – a different histology for not so different gastric adenocarcinoma: a case report Immunotherapy for Gastroesophageal Cancer Prognostic gene expression profiling in esophageal cancer: a systematic review Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectives Positioning of second-line treatment for advanced gastric and gastroesophageal junction adenocarcinoma From molecular classification to targeted therapeutics: the changing face of systemic therapy in metastatic gastroesophageal cancer Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification Adjuvant and/or neoadjuvant therapy for gastric cancer? A perspective review

P2860

Q24186222-E0BF862C-B879-42BD-B820-1E7033E4252C Q24602875-9E4A271B-A5BC-4B09-BB5C-226619C2F495 Q24604411-5371E1EA-603C-4379-BDD3-0534FEB15530 Q24633301-993DD29B-F8B8-4C44-98B7-A3C09F19DEF7 Q24649684-95D194BE-BB0B-4071-A4D6-66B3E91B336F Q26740567-6C43C530-F7DD-49B1-82F4-3DE13667961C Q26741530-AEEB922B-B889-4A0D-8D96-124A6B7BB2F6 Q26745453-21B9ED25-23ED-499B-9B79-0B8481B4ABEA Q26747420-0687AB36-1F00-4D2F-8963-1E4FA6FB8B6A Q26747708-0602FEBF-4F30-487D-B3F0-A28141B44907 Q26764934-2C78A219-773B-4D8F-9F31-BA84542AE4D7 Q26765208-29E462D9-66BF-4E5F-B8FE-4D9037F92486 Q26765314-3FBD0B66-028B-4008-B0C8-7C4B180141B0 Q26771399-E80ED427-218A-41B8-8034-8B1BC258D726 Q26771424-25E46964-1B5D-40AA-A263-A0447A672630 Q26774720-BD2D5032-4725-4FBB-A268-0257A4768332 Q26776190-C6162D53-FE3A-4CCD-A92F-F19F0ADEDF74 Q26778027-BC1A3251-4FA2-4FE2-A662-8ADB993ADA0B Q26779217-30106E9E-FE2A-49A4-8252-8AFC69FE93CB Q26780298-1B7B5399-84CE-4810-A850-F5D618DA4769 Q26781038-32C8974C-C253-4C17-BD24-ED4982314559 Q26785665-2002A327-CEDD-4527-9636-F1CB3278CE33 Q26798400-0A7CE316-225D-49AB-8DA6-37811D5BD879 Q26798420-252FD8B2-1D41-4DA8-91F5-EBDE0F5534FE Q26799748-2A67E844-5687-40E8-A955-26D6064AA9CD Q26801289-285915FA-C52B-46BE-A427-C2087508A7D5 Q26823515-FCF44DC8-446D-42D6-8068-1456D0641A1E Q26865057-0381AB59-8256-4427-AF2D-CF1B78DFDA34 Q26999701-BD493527-3FF5-434D-A1BC-D64334AF7B82 Q27002415-496F191F-27D2-4EC5-AA0E-A9A0F1433763 Q27025793-F688F9AA-D732-4D5D-ADBC-598DEBB4C601 Q27026877-CEBC083A-2388-42ED-81C1-53270346C900 Q27497441-F8C58451-9850-4F8E-AE52-CCFDC28699E7 Q28069873-9EF0BE94-6986-4C9B-975D-9AB39B7BBD12 Q28073948-39FA8506-D492-42FB-9981-34B8E52FC4F0 Q28077666-B6D6F9BC-E8B5-4BBE-8220-CB7BED5363E8 Q28079750-EF3BA67E-EC04-4960-A715-16E66F1C12DB Q28082921-DC17A01F-B41F-44D3-B674-2CEBA49CAF99 Q28084888-22429D89-F184-4A50-AE1F-C795D1661FB6 Q28088619-A927D778-5DC9-45D7-A1DE-7F3A76983D4B

P2860

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

http://www.wikidata.org/entity/Q33313072

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

@ast

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

@en

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

@nl

type

label

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

@ast

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

@en

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

@nl

prefLabel

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

@ast

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

@en

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

@nl

P1433

Q33313072-075D5343-734D-4D14-9E33-FB9882CEA6B3

P1476

Q33313072-D4EB1C69-698B-45AA-AB37-62270093E7A0

P2093

Q33313072-3B9A638C-EDEF-415B-890B-2A271A0192C4

Q33313072-3BFF0FAD-36EE-4A99-ABBB-F1960D522972

Q33313072-6B0EC7C1-9926-4F80-9DCB-9D07B8F072DD

Q33313072-9D69CE34-3C58-443E-89E8-2427B850029A

Q33313072-B098547C-645A-40FB-B7BA-2CB1A4A7190D

Q33313072-CAEA70A1-3179-46C5-BD4B-8D27C9413705

Q33313072-D2CFD07E-9206-4D69-8E70-0BEB8A036C6D

Q33313072-EB852C3B-B880-4153-BD93-35A7BCF16030

Q33313072-FB6D8D52-40E2-4566-B3E1-1288212A4F06

P304

Q33313072-6316E16E-1F7D-419B-9595-95C8D672BA47

P31

Q33313072-9A82ED30-15D4-44C0-88B6-FD3C99520ABE

P356

Q33313072-4B2AD1FE-5F28-40A9-ABB0-4F7841FA64A0

P407

Q33313072-5CBB3342-FB98-4D9B-A645-696CB920CA5E

P433

Q33313072-0CC1D48C-AFD5-4530-87A9-EA4F035E7683

P478

Q33313072-105C9973-55B2-4F25-8F52-A551F0332DA8

P50

Q33313072-175AAD36-BBDE-429A-A2C3-3F074FD20CF4

Q33313072-88A80D1C-7FAB-421F-8177-AE3FBEF5989B

P577

Q33313072-D64E0D60-F686-4033-AF79-5DB4C48B2D34

P698

Q33313072-FF389469-33B9-49B1-BFE8-389ADFCA8F56

P356

P1433

The New England Journal of Medicine

P1476

Capecitabine and oxaliplatin for advanced esophagogastric cancer

@en

P2093

Andrew Richard Norman

http://www.w3.org/2001/XMLSchema#string

Fareeda Coxon

http://www.w3.org/2001/XMLSchema#string

Francis Daniel

http://www.w3.org/2001/XMLSchema#string

Gary Middleton

http://www.w3.org/2001/XMLSchema#string

Jacqueline Oates

http://www.w3.org/2001/XMLSchema#string

Marianne Nicolson

http://www.w3.org/2001/XMLSchema#string

Sheela Rao

http://www.w3.org/2001/XMLSchema#string

Timothy Iveson

http://www.w3.org/2001/XMLSchema#string

Upper Gastrointestinal Clinica ...... nstitute of the United Kingdom

http://www.w3.org/2001/XMLSchema#string

P304

36-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA073149

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

358

http://www.w3.org/2001/XMLSchema#string

P50

David Cunningham

Naureen Starling

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18172173

http://www.w3.org/2001/XMLSchema#string